MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer.
暂无分享,去创建一个
Michael Reiss | Qifeng Yang | M. Reiss | Yibin Kang | G. Hu | Qifeng Yang | B. Haffty | J. Au | Feng Li | Yong Wei | M. A. Blanco | Bruce G Haffty | Yibin Kang | Guohong Hu | Yong Wei | Jessie L-S Au | Robert A Chong | Mario A Blanco | Feng Li | Robert A. Chong | R. Chong
[1] Yibin Kang. Functional genomic analysis of cancer metastasis: biologic insights and clinical implications , 2005, Expert review of molecular diagnostics.
[2] A. Nobel,et al. Concordance among Gene-Expression – Based Predictors for Breast Cancer , 2011 .
[3] D. Millhorn,et al. Bcl-2/adenovirus E1B 19 kDa interacting protein-3 knockdown enables growth of breast cancer metastases in the lung, liver, and bone. , 2005, Cancer research.
[4] I. Fidler,et al. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.
[5] W. Hiddemann,et al. Increase of P-glycoprotein-mediated drug resistance by hsp 90b , 1996 .
[6] A. Zetterberg,et al. Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. , 1995, Cancer research.
[7] E. Ruoslahti,et al. Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. , 2004, Cancer cell.
[8] Daniel Birnbaum,et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.
[9] W. Birchmeier,et al. Met, metastasis, motility and more , 2003, Nature Reviews Molecular Cell Biology.
[10] P. Comoglio,et al. Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion. , 2002, Cancer research.
[11] M. Xiong,et al. Long-term tumor-free survival from treatment with the GFP–TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells , 2002, Oncogene.
[12] Yudong D. He,et al. A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .
[13] C. Cordon-Cardo,et al. A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.
[14] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[15] S. Ramaswamy,et al. Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.
[16] Eric S. Lander,et al. Genomic analysis of metastasis reveals an essential role for RhoC , 2000, Nature.
[17] P. Steeg. Tumor metastasis: mechanistic insights and clinical challenges , 2006, Nature Medicine.
[18] Y. Lim,et al. Syndecan-2 Mediates Adhesion and Proliferation of Colon Carcinoma Cells* , 2002, The Journal of Biological Chemistry.
[19] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[20] T. Golub,et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma , 2005, Nature.
[21] J. Massagué,et al. Cancer Metastasis: Building a Framework , 2006, Cell.
[22] Joon-Oh Park,et al. MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling , 2007, Science.
[23] Andy J. Minn,et al. Genes that mediate breast cancer metastasis to lung , 2005, Nature.
[24] A. Ballestrero,et al. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Cooperates with Anticancer Drugs to Overcome Chemoresistance in Antiapoptotic Bcl-2 Family Members Expressing Jurkat Cells , 2004, Clinical Cancer Research.
[25] J. Foekens,et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.
[26] Paula D. Bos,et al. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis , 2007, Nature.
[27] David A Hess,et al. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability , 2009, Journal of cellular and molecular medicine.
[28] Robert A. Weinberg,et al. Metastasis genes: A progression puzzle , 2002, Nature.
[29] A. Harris,et al. The role of the hypoxia-inducible BH3-only proteins BNIP3 and BNIP3L in cancer , 2007, Cancer and Metastasis Reviews.
[30] Joe W. Gray,et al. Translating insights from the cancer genome into clinical practice , 2008, Nature.
[31] L. Chin,et al. Comparative Oncogenomics Identifies NEDD9 as a Melanoma Metastasis Gene , 2006, Cell.
[32] Y. Lim,et al. Identification of a novel protein, LYRIC, localized to tight junctions of polarized epithelial cells. , 2004, Experimental cell research.
[33] Robert Tibshirani,et al. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene‐expression subtypes of breast cancer , 2006, Genes, chromosomes & cancer.
[34] L. Sreerama,et al. Primary breast tumor levels of suspected molecular determinants of cellular sensitivity to cyclophosphamide, ifosfamide, and certain other anticancer agents as predictors of paired metastatic tumor levels of these determinants , 2001, Cancer Chemotherapy and Pharmacology.
[35] Lei Xu,et al. GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[36] H. Maeda,et al. Antiapoptotic effect of haem oxygenase-1 induced by nitric oxide in experimental solid tumour , 2003, British Journal of Cancer.
[37] Joel Greshock,et al. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization , 2005, Breast Cancer Research.
[38] Christian A. Rees,et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[39] E. Lander,et al. A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.
[40] P. Fisher,et al. Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. , 2005, Gene.